CP-868,596,
crenolanib,
Crenolanib,
670220-88-9,
Crenolanib (CP-868596),
CP-868596,
ARO-002,
UNII-LQF7I567TQ,
LQF7I567TQ,
CP-868596 (Crenolanib),
CP-868,596,
[1-[2-[5-(3-Methyloxetan-3-ylmethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-yl]amine,
1-(2-(5-((3-Methyloxetan-3-yl)methoxy)-1H-benzo-[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine,
CP868569,
1-[2-[5-[(3-Methyl-3-oxetanyl)methoxy]-1-benzimidazolyl]-8-quinolyl]-4-piperidinamine,
1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]quinolin-8-yl]piperidin-4-amine,
J-502712,
1-(2-{5-[(3-Methyloxetan-3-yl)methoxy]-1H-benzimidazol-1-yl}quinolin-8-yl)piperidin-4-amine,
1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1H-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine,
CP868596,
Crenolanib [USAN:INN],
6T2,
Crenolanib (USAN),
crenolanib-cp-868596,
cc-84,
Crenolanib, CP868569,
Crenolanib,CP-868596,
MLS006010956,
Crenolanib - CP-868569,
GTPL7882,
SCHEMBL2730601,
CHEMBL2105728,
ARO 002,
EX-A215,
DYNHJHQFHQTFTP-UHFFFAOYSA-N,
BDBM185149,
HMS3656F19,
AOB87312,
BCP02384,
ZINC3820043,
ABP000963,
MFCD21609260,
s2730,
AKOS026750597,
BCP9000551,
CS-0566,
DB11832,
RL04552,
SB16603,
NCGC00346658-01,
NCGC00346658-09,
BC261910,
HY-13223,
SMR004702760,
SY237889,
AB0008010,
CP 868596,
CP-868569,
CP-868569),
FT-0665221,
SW218293-2,
X7517,
MFCD21609260 (95%),
D10102,
W-5851,
CP-868569, 670220-88-9,
1-{2-[5-(3-Methyl-oxetan-3-ylmethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine,
Crenolanib [USAN],
D02AYJ,
D0J1GR,
Crenolanib(CP-868596),
C26H29N5O2,
ACN-031571,
CID10366136,
A8307,
A11052,
1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzoimidazol-1-yl]quinolin-8-yl]piperidin-4-amine,
4-Piperidinamine, 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1H-benzimidazol-1-yl]-8-quinolinyl]-,